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ABSTRACT 
 
Aims : To compare the effects of Magnesium sulphate regimens – Dhaka regimen with Pritchard regimen. The 
efficacy of controlling convulsions , In preventing recurrent convulsions, The incidence of complications.  
Materials and Methods: The present study was conducted in 50 patients with antepartum eclampsia were recruited. 
Patients were divided into two groups of 25 each, Group A comprising of 25 patients who were given the Dhaka 
regimen, Group B comprising of 25 patients who were given the Pritchard regimen. Results: The mean age in 
patients on Dhaka regimen was 21.6 years whereas the mean age in in patients on Pritchard regimen was 21.8 years. 
There was no significant difference observed in Premonitory symptoms between the two regimen groups p > 0.05. 
In the present study there was no significant difference in past history of eclampsia/ preeclampsia was observed 
between the two regimen groups In the present study it was observed that in both the groups majority of patients 
were admitted between 0 – 6 hrs Dhaka regimen (88%), pritchard (84%), there was no significant difference in mean 
convulsion to admission interval in either groups p >0.05. Maintainence dose of MgsO4 was given when patellar 
reflex was present, respiratory rate> 12/min, urine output the previous 1hr exceeding 30 ml .In the present study it 
was observed that the toxic levels of Magnesium reached earlier in Pritchard whereas in Dhaka it was not the  same.  
Conclusion: The study clearly shows that Dhaka regimen is equivalent to Pritchard regimen in controlling 
convulsions and preventing recurrence of convulsions, with no difference. 
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Introduction 
 
Eclampsia is derived from the Greek word meaning 
flash of lightening, to shine forth. Eclampsia is defined 
as the occurrence of generalized tonic-clonic 
convulsion in women with pre-eclampsia not caused by 
any other neurological or medical disorders. Pritchard 
et al [1] suggested that the dose of magnesium sulphate 
should be limited in women who are known to be or 
appear to be small (Low weight). Administering 
Pritchard regime might prove to be hazardous with a 
possibility of respiratory failure. There was a need for 
modification and to formulate a regime for women of 
tropical world physique. Indian women, especially  
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from low socioeconomic strata, weigh much less than 
their counterparts in the western world. Various 
regimens with different dosages have "been used over 
the years, question still remains about the 'minimum 
effective dose' of magnesium sulphate. “If a woman is 
known to be or appear to be small, the dose should 
probably be limited”2." WinitPhuapradit et al"[2].One 
may also speculate that Magnesium sulphate dosing 
should vary according to the patients weights or body 
mass index. However this has never adequately been 
evaluated." Andrea Witln  et al[3]. . A smaller study 
carried out at Dhaka Medical College by Begum et al4, 
at the same time as the Collaborative Eclampsia Trial 
Group[6 ](CETG) came to exactly the same 
conclusions. The main difference between these 2 
studies was the dosage regimen of magnesium 
sulphate.This study compares the Pritchard Regimen 
with Dhaka regimen of magnesium sulphate in the 
management of antepartum eclampsia. Eclampsia now 
a rare disease in developed countries (1:2000 
deliveries) where modern antenatal care is available to 
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all pregnant women, as a result preeclampsia is 
detected early and treated effectively so that the 
convulsive stage is seldom reached. 
 
Materials and methods 
 
The present study was conducted in the Department of 
Obstetrics and gynaecology, government general 
hospital, GGH from September 2015 to august 2016. A 
total of 50 patients with antepartum eclampsia were 
recruited for the present study. Magnesium sulphate 
was used in control of convulsions. 25 patients were 
put under the Pritchard regimen and other 25 were 
enrolled under Dhaka regimen.  
Inclusion Criteria: 50 consecutive patients with 
antepartum eclampsia, irrespective of parity and 
gestational age were included in the study. 
Exclusion Criteria:  
 Patients with convulsions due to causes other than 
eclampsia Referred patients, who received magnesium 
sulphate loading dose before admission. : A detailed 
history regarding age, parity, gestational age, number 
of convulsions, duration of symptoms of pregnancy 
induced Hypertension, H/o imminent symptoms were 
taken from close relatives and also from the patient if 
she is conscious. Any past history of hypertension (or) 
renal disease (or) Eclampsia in previous pregnancy was 
elicited. Patients who had at least 3 antenatal visits, 1 
in each trimester, and 2 doses of TT injection were 
taken as booked case. 
 
Results 
 
Patients were divided into two groups of 25 each, 
Group A comprising of 25 patients who were given the 
Dhaka regimen, Group B comprising of 25 patients 
who were given the Pritchard regimen. 
 
Table 1:  Distribution of patients according to Age 
 
Age group Dhaka regimen Pritchard 
No of Patients % No of   Patients % 
15-20 11 44 11 44 
21-25 13 52 13 52 
26-30 1 4 1 4 
Total 25 100 25 100 
Mean±SD 21.6 ± 2.4 21.8 ± 2.38 
 
The mean age in patients on Dhaka regimen was 21.6 years whereas the mean age in in patients on Pritchard 
regimen was 21.8 years. There was no statistical difference in the mean age between either groups (p> 0.05). On age 
wise distribution it was observed that majority of the cases were in the age group of 21 - 25 years in both grou 
Table  2 : Comparison of premonitory symptoms 
 
Premonitory Symptoms Group A Group B 
No of Patients % No of Patients % 
Nil 18 72 14 56 
Blurring of Vision 0 0 1 4 
Headache 0 0 2 8 
Vomiting 0 0 1 4  
Headache+vomiting 7 28 5 20 
Total 25 100 25 100 
X
2
 value 6.83  p value= 0.233 
 
There was no significant difference observed in Premonitory symptoms between the two regimen groups p > 0.05. 
Table  3 : Comparison of past history of preeclampsia/ eclampsia 
 
Past history Group A Group B 
No of Patients % No of Patients % 
Absent 20 80 22 88 
Present 5 20 3 12 
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Total 25 100 25 100 
X
2
 value 1.72  pvalue= 0.423 
In the present study there was no significant difference in past history of eclampsia/ preeclampsia was observed 
between the two regimen groups p > 0.05. 
Table   4 : Comparison of Convulsion to admission interval 
 
Convulsions to admission Interval Group A Group B 
No of Patients % No of Patients % 
0 – 6 22 88 21 84 
7 – 12 3 12 4 16 
Mean 3.40 ± 2.18 4 ± 2.2 
t value 0.965 pvalue= 0.339 
 
In the present study it was observed that in both the groups majority of patients were admitted between 0 – 6 hrs 
Dhaka regimen (88%), pritchard (84%), there was no significant difference in mean convulsion to admission interval 
in either groups p >0.05. 
Table  5: Comparison of No. of doses of Mg sulphate given 
 
No. of doses Group A  Group B  
of MgSo4 No of  % No of % 
 Patients   Patients  
1 1  4 15 60 
2 6  24 7 28 
3 8  32 3 12 
4 5  20 0 0 
5 4  16 0 0 
6 1  4 0 0 
Mean doses 3.32±1.2  1.52 ±0.7 
Total 25  100 25 100 
X
2
 value 24.6  Pvalue< 0.001 
 
 
Maintainence dose of MgSo4 was given when patellar 
reflex was present, respiratory rate> 12/min, urine 
output the previous 1hr exceeding 30 ml .In the present 
study it was observed that the toxic levels of 
Magnesium reached earlier in Pritchard whereas in 
Dhaka it was not the same. 
 
Discussion 
 
The Collaborative Eclampsia Trial (CET) et al [5], 
published in 1985 found a lowered risk of recurrent 
convulsions with little difference in maternal, perinatal 
morbidity and mortality comparing magnesium 
sulphate with diazepam and phenytoin and concluded 
that" there is now a compelling evidence in favour of 
magnesium sulphate rather than diazepam or phenytoin 
in treatment of eclampsia". Similar findings were also 
reported by Crowther et al[6 ]their study. Appleton  
and Lucas  in different studies established the 
superiority of magnesium sulphate over phenytoin 
validating its long practiced use. Duley et al7 compared 
magnesium sulphate with Lytic cocktail establishing its 
superiority and suggested the abandoning of Lytic 
cocktail. In 2002 the results of the 'Magpie trial'et al 
[8] another large multi-centric trial was published 
which showed beyond any reasonable doubt the 
efficacy of magnesium sulphates in reducing the risk of 
eclampsia. The Cochrane review of 20026, which 
analyzed the data from most of the studies available on 
magnesium sulphate, has concluded magnesium 
sulphate as being superior to the other anti convulsants 
The Collaborative Trial provided vital evidence that 
magnesium reduces the risk of recurrent seizures 
compared to other standard agents like diazepam and 
phenytoin. In the study of eclampsia collaborative trial 
Group (1995) 64% were primis. In the study by 
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N.W.M. Hospital, Bombay 1989, 64.9% were primis. 
According to Mudaliar over 75% were primis. In a 
study by Lalkoand et al (1997) 57.3% were primis. In 
our study 41 cases were primis. A prospective study by 
Bhalerao et al9( 2013) for 3 years in 55 eclampsia 
patients 40 were primigravidas. In our study Dhaka 
regimen and Pritchard regimen  20 (80%) were primis. 
All the cases received maintenance doses. Maintenance 
dose of MgSO4 was given when patellar reflex was 
present, respiratory Rate>12/min, urine output the 
previous 1hr exceeded 30ml. Mean number 
maintenance of doses given in Dhaka regimen was 3.32 
and in Pritchard was 1.52, Indicating lower serum 
magnesium levels in Dhaka group than in Pritchard 
group. Thus toxic levels of magnesium are less 
common in Dhaka group than in Pritchard 
group.Begum R et al[10] – in 2001 used a low dose 
(Dhaka) Magnesium Sulphate regime for eclampsia. 
And concluded that Half of the standard dose of 
magnesium sulphate appeared to be sufficient to 
control convulsions effectively and serum levels of 
magnesium remained lower than levels which produce 
toxicity.In our study out of 25 cases of Pritchard 
Regimen 15 cases induced with misoprostol and 1 case 
with cerviprime. Out of 25 cases of Dhaka Regimen 11 
cases (44%) were induced with misoprostol, 1 case 
(4%) with cerviprime and 3 cases (12%) were induced 
using both cerviprime and misoprostol. 19 cases (38%) 
did not need any inducing agent as they delivered 
spontaneously or were taken for L.S.C.S. Out of 25 
cases of Pritchard regimen 12 cases (44%) delivered by 
normal vaginal non-instrumental mode, 2 cases (8%) 
by vaginal instrumental mode and 11 (44%) cases by 
LSCS. Out of 25 cases of Dhaka Regimen 12 cases 
(52%) delivered by normal vaginal non-instrumental 
mode, 3 cases (12%) by vaginal instrumental mode and 
10 (40%) cases by LSCS. Out of 33 cases delivered by 
LSCS, 2 cases were due to failed induction, 1 in Dhaka 
group and 1 in Pritchard group. 13 cases were due to 
foetal distress, 6 cases were due to CPD. 
 
Conclusion 
 
Magnesium sulphate is the anticonvulsant drug of 
choice in woman with eclampsia. The present study 
provides further strong support for the routine use of 
magnesium sulphate for eclampsia convulsions. The 
present study showed that Dhaka Regimen is efficient 
in controlling & preventing recurrence of convulsions. 
The results showed same outcome with reduction of 
dose of magnesium sulphate therapy and raises 
question whether high dose regimens are really 
necessary and safer. The study clearly shows that 
Dhaka regimen is equivalent to Pritchard regimen in 
controlling convulsions and preventing recurrence of 
convulsions, with no difference in the incidence of 
complications. 
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